Clinical Governance

Medical Review Board & Clinical Policy

To guarantee clinical accuracy, safety context, and regulatory precision, Peptides Agora educational guides and drug monographs undergo rigorous peer review by licensed physicians (MD/DO), clinical pharmacists (PharmD), and pharmacological researchers (PhD).

1. Qualifications of Medical Reviewers

Our medical review board members must possess active credentials and demonstrated expertise in one or more core disciplines:

  • Endocrinology & Metabolic Medicine (MD/DO): Overseeing incretin analogs, GLP-1/GIP receptor pathways, and metabolic therapies.
  • Clinical Pharmacy & Compounding (PharmD, RPh): Specializing in sterile preparation standards (USP <797>), 503A/503B regulatory law, and stability chemistry.
  • Molecular Pharmacology & Biochemistry (PhD): Analyzing receptor binding affinities ($K_d, EC_50$), signal transduction pathways, and in vivo pharmacokinetics.

2. The 5-Point Clinical Review Workflow

1. Clinical Indication Accuracy: Verifying that FDA-approved indications are clearly segregated from investigational or off-label research.
2. Risk & Contraindication Auditing: Ensuring all documented black-box warnings, side effects, and drug-drug interactions reflect current clinical evidence.
3. Absence of Dosing Directives: Enforcing strict prohibitions against individual prescription advice, injection guidance, or unmonitored self-administration protocols.
4. Regulatory & Compounding Status: Confirming up-to-date alignment with FDA bulk substances lists and statutory compounding restrictions.
5. Primary Source Verification: Cross-referencing all statistical claims against original trial publications in high-impact medical journals.

3. Continuous Review & Recertification Cycle

Peptide therapeutics and compounding regulations evolve rapidly. All clinical monographs are reviewed on a rolling 6-month schedule, or immediately following new FDA regulatory action, safety alerts, or Phase 3 trial publications.

Read Our Full Medical DisclaimerUnderstand the educational scope of Peptides Agora publications.
Medical Disclaimer →